Recently, LSD1 inhibition was shown to augment CD8+ T cell infiltration into tumors, suppressing tumor burden via enhanced chemokine expression (6) and by inducing endogenous retroviral elements leading to the activation of a type 1 IFN signature, which stimulated anti-tumor T cell immune function (22). This evidence concerns the gene CD8A and neoplasm.